Clinical Trials Directory

Trials / Conditions / Stage IV Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8

Stage IV Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8

7 registered clinical trials studyying Stage IV Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingImmune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
NCT06349642
Mayo Clinic—
Active Not RecruitingTesting the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers
NCT05691504
National Cancer Institute (NCI)Phase 1
RecruitingPersonalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Soli
NCT05269381
Mayo ClinicPhase 1 / Phase 2
RecruitingTesting the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tu
NCT04704661
National Cancer Institute (NCI)Phase 1
Active Not RecruitingTesting the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel a
NCT03914612
National Cancer Institute (NCI)Phase 3
Active Not RecruitingTesting the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and C
NCT03660826
National Cancer Institute (NCI)Phase 2
Active Not RecruitingCabozantinib S-malate and Nivolumab in Treating Patients With Advanced, Recurrent, or Metastatic Endometrial C
NCT03367741
National Cancer Institute (NCI)Phase 2